Renaissance Capital logo

TCON News

US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs

SHAK

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs this past week than any week in 2014, a year that had over 100 from the sector. With 14 IPOs to date, January 2015 fell...read more

TRACON Pharmaceuticals prices IPO at $10, well below $12-$14 range

TCON

TRACON Pharmaceuticals, a biotech developing combination therapies with VEGF inhibitors to treat cancers, raised $36 million by offering 3.6 million shares at $10, well below the $12 to $14 range. The company also sold 500,000 shares at the offer price to shareholder NEA in a concurrent private placement. Insiders have also indicated an interest in purchasing up to $8.2 million of...read more

Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care

SHAK

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the twelve deals are health care, as last year's most popular sector continues to outperform. Assuming they all price, there...read more

Cancer biotech TRACON Pharmaceuticals sets terms for $47 million IPO

TCON

TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise $47 million by offering 3.6 million shares at a price range of $12 to $14. At the midpoint of the proposed range, TRACON Pharmaceuticals would command a fully diluted market value of $164 million. ...read more